TriSalus Life Sciences
TLSI
68 hedge funds and large institutions have $198M invested in TriSalus Life Sciences in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 18 reducing their positions, and 8 closing their positions.
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
3% more funds holding
Funds holding: 66 → 68 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less ownership
Funds ownership: 81.46% → 80.46% (-1%)
2% less capital invested
Capital invested by funds: $202M → $198M (-$3.98M)
56% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$9.32M |
| 2 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$5.12M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$2.14M |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
+$322K |
| 5 |
AA
AlphaCentric Advisors
San Juan,
Puerto Rico
|
+$248K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IM
Islet Management
New York
|
-$4.88M |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$3.9M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
-$2.33M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.13M |
| 5 |
JP Morgan Chase
New York
|
-$1.94M |
TLSI Hedge Fund Activity: Q4 2021 in Review
68 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q4 2021, worth a combined $198M — down 2% from $202M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new TLSI positions and 8 closed out — a net gain of 3 holders — while 8 added to existing stakes and 18 trimmed.
The largest buyer was Weiss Asset Management, adding an estimated $9.32M. The largest seller was Islet Management, exiting entirely with an estimated $4.88M sold.
- 68 institutional investors held TriSalus Life Sciences (TLSI) as of Q4 2021, up from 66 in Q3 2021.
- Funds reported $198M of TriSalus Life Sciences stock for Q4 2021, down 2% quarter-over-quarter.
- 11 funds opened new TriSalus Life Sciences positions in Q4 2021 and 8 closed out, a net change of +3 holders.
- The largest TriSalus Life Sciences buyer in Q4 2021 was Weiss Asset Management, an estimated $9.32M added.
- The largest TriSalus Life Sciences seller in Q4 2021 was Islet Management, an estimated $4.88M sold.
Based on aggregated 13F filings for Q4 2021.